A detailed history of Advisor Group Holdings, Inc. transactions in Dbv Technologies S.A. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 117 shares of DBVT stock, worth $88. This represents 0.0% of its overall portfolio holdings.

Number of Shares
117
Previous 855 86.32%
Holding current value
$88
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.54 - $1.05 $398 - $774
-738 Reduced 86.32%
117 $0
Q4 2023

Feb 12, 2024

SELL
$0.7 - $1.33 $52 - $99
-75 Reduced 8.06%
855 $0
Q3 2023

Nov 13, 2023

SELL
$1.3 - $1.88 $85 - $124
-66 Reduced 6.63%
930 $1,000
Q2 2023

Aug 10, 2023

BUY
$1.42 - $2.23 $200 - $314
141 Added 16.49%
996 $1,000
Q2 2021

Aug 02, 2021

BUY
$5.32 - $6.53 $399 - $489
75 Added 9.62%
855 $4,000
Q4 2020

Feb 10, 2021

BUY
$1.38 - $3.01 $760 - $1,658
551 Added 240.61%
780 $2,000
Q3 2020

Nov 12, 2020

SELL
$1.58 - $4.77 $6,794 - $20,510
-4,300 Reduced 94.94%
229 $0
Q2 2020

Aug 14, 2020

SELL
$3.74 - $6.28 $23,775 - $39,921
-6,357 Reduced 58.4%
4,529 $20,000
Q1 2020

May 18, 2020

BUY
$2.33 - $12.98 $25,364 - $141,300
10,886 New
10,886 $43,000

Others Institutions Holding DBVT

About DBV Technologies S.A.


  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $143M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.